United States · Investor

SB Life Science

No cheque observed since Jul 2008, after 6 earlier cheques, and the website is parked.

DormantGrowth equity

Series CSeries DSeries AAdvertising PlatformsMobile Advertising

Cheques on record
0%of best year0cheques in 12 months, 6 on record
Since the last cheque6689days00hrs00min00sec
Median round$26MRounds led0 of 6Exits3 from the portfolioMostly inUnited States, 83%
Pitch SB Life Science

SB Life Science highlights

  1. 01

    6 rounds on record

  2. 02

    Mostly Series C and Series D: 67% of its rounds

  3. 03

    3 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
Advertising PlatformsMobile Advertising
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first6 appearances

  1. 2008

    1 round

  2. Jul
    Gemin X PharmaceuticalsSeries C · CA · siliconindia.com$38MWith 12 others
  3. 2007

    1 round

  4. Apr
    CircuLiteSeries B · US$5.0MWith 4 others
  5. 2005

    2 rounds

  6. Dec
    Optimer PharmaceuticalsSeries D · US$22MWith 7 others
  7. Feb
    Perlegen SciencesSeries D · US · allbusiness.com$74MWith 14 others
  8. 2004

    1 round

  9. Feb
    Kadmus PharmaceuticalsSeries A · US$15MWith 6 others
  10. 2003

    1 round

  11. Jan
    Perlegen SciencesSeries C · US$30MWith 8 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed3 in all

CircuLiteBought by HeartWare International$30MDec 2013
Optimer PharmaceuticalsBought by Cubist Pharmaceuticals$535MJul 2013
Gemin X PharmaceuticalsBought by Cephalon$525MMar 2011

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as SB Life Science. A count of rooms they were both in, not a relationship either has claimed.

BioFrontier PartnersVC firm2rounds togetherCMEA VenturesVC firm2rounds togetherCSK Venture CapitalVC firm2rounds togetherMaverick CapitalVC firm2rounds togetherProQuest InvestmentsVC firm2rounds togetherSanderling VenturesVC firm2rounds together

Quick answers about SB Life Science

What does SB Life Science invest in?

SB Life Science invests most often at Series C and Series D (67% of the rounds on record), in sectors such as Advertising Platforms and Mobile Advertising.

How active is SB Life Science?

6 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2008.

How big are SB Life Science's cheques?

The median round it joins is $26M.

Does SB Life Science lead rounds?

Rarely, if at all: none of its 6 investments on record names it as the lead.

Where does SB Life Science invest?

Most of the companies it backs are in the United States (83%) and Canada (17%).

Is SB Life Science investing now?

It looks quiet: no investment on record since Jul 2008.

Who does SB Life Science invest alongside?

Most often BioFrontier Partners (2 rounds together), CMEA Ventures (2 rounds together) and CSK Venture Capital (2 rounds together).

What kind of investor is SB Life Science?

SB Life Science is a growth equity firm based in United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it